Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Sales | 11,782 | 8,354 | 16,732 | 14,011 | 6,464 |
| Cost of Goods | 1,288 | 8,700 | 415 | 228 | 269 |
| Gross Profit | 10,494 | -346 | 16,317 | 13,783 | 6,195 |
| Operating Expenses | 60,433 | 74,162 | 82,955 | 82,997 | 71,013 |
| Operating Income | -49,651 | -73,808 | -66,223 | -68,986 | -64,549 |
| Interest Expense | 33 | 36 | 37 | 39 | 41 |
| Other Income | -19 | -136 | 31 | 126 | -21 |
| Pre-tax Income | -49,703 | -73,980 | -66,229 | -68,899 | -64,611 |
| Income Tax | 119 | 184 | 110 | 86 | 59 |
| Net Income Continuous | -49,822 | -74,164 | -66,339 | -68,985 | -64,670 |
| Net Income | $-49,822 | $-74,164 | $-66,339 | $-68,985 | $-64,670 |
| EPS Basic Total Ops | -0.27 | -0.40 | -0.36 | -0.37 | -0.36 |
| EPS Basic Continuous Ops | -0.27 | -0.40 | -0.36 | -0.37 | -0.36 |
| EPS Diluted Total Ops | -0.27 | -0.40 | -0.36 | -0.37 | -0.36 |
| EPS Diluted Continuous Ops | -0.27 | -0.40 | -0.36 | -0.37 | -0.36 |
| EBITDA(a) | $-48,354 | $-72,519 | $-65,145 | $-68,028 | $-63,738 |